Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M269Revenue $M26.4Net Margin (%)-109.0Z-Score-6.4
Enterprise Value $M357EPS $-1.3Operating Margin %-227.2F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-102.9Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio4.1Cash flow > EarningsN
Price/Sales5.65-y EBITDA Growth Rate %-1.1Current Ratio4.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-22.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M175ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with AMRN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRNJohn Burbank 2013-03-31 Sold Out -0.08%$6.965 - $9.16
($8.27)
$ 1.54-81%Sold Out0
AMRNJohn Burbank 2012-12-31 Buy 0.08%$7.68 - $12.6
($10.8)
$ 1.54-86%New holding, 250000 sh.250,000
AMRNGeorge Soros 2012-09-30 Sold Out -0.06%$11.17 - $15.49
($13.55)
$ 1.54-89%Sold Out0
AMRNGeorge Soros 2012-06-30 Buy 0.06%$9.47 - $14.74
($11.35)
$ 1.54-86%New holding, 300000 sh.300,000
AMRNGeorge Soros 2011-09-30 Sold Out -0.058%$8.95 - $14.82
($12)
$ 1.54-87%Sold Out0
AMRNGeorge Soros 2011-06-30 Reduce-0.04%$7.39 - $19.5
($15)
$ 1.54-90%Reduce -56.15%285,000
AMRNGeorge Soros 2011-03-31 Reduce-0.04%$7.03 - $9.33
($8.1)
$ 1.54-81%Reduce -42.66%650,000
AMRNGeorge Soros 2010-12-31 Buy 0.12%$2.49 - $8.49
($4.48)
$ 1.54-66%New holding, 1133500 sh.1,133,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THERO JOHN FPresident, Chief Exec. Officer 2014-11-12Buy50,000$0.8385.54view
Farrell Michael JamesController 2014-11-11Buy5,500$0.8483.33view
Southpoint Capital Advisors LP10% Owner 2006-04-20Sell0$083.33view

Press Releases about AMRN :

    Quarterly/Annual Reports about AMRN:

    News about AMRN:

    Articles On GuruFocus.com
    Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 23 2014 
    Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN Jan 07 2013 
    Steven Cohen Adds Amarin Corp. Awaiting Drug Approval, Buys Hyatt Hotels Mar 28 2012 
    Soros Funds’ Great Britain Buys and Sells Apr 13 2011 


    More From Other Websites
    Amarin to Host Fourth Quarter and Fiscal Year 2014 Earnings Conference Call and Webcast Live on... Mar 02 2015
    What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog Mar 02 2015
    Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog Feb 28 2015
    Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog Feb 27 2015
    Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog Feb 27 2015
    Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog Feb 27 2015
    Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog Feb 27 2015
    What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog Feb 26 2015
    Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl)... Feb 26 2015
    Amarin and Eddingpharm Announce Agreement to Develop and Commercialize Vascepa(R) (icosapent ethyl)... Feb 26 2015
    Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog Feb 25 2015
    Should You Buy Amarin Corporation (AMRN) Ahead of Earnings? - Tale of the Tape Feb 25 2015
    Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog Feb 24 2015
    Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog Feb 24 2015
    Will Ingram Micro (IM) Miss Earnings Estimates in Q4? - Analyst Blog Feb 24 2015
    What's in Store for OmniVision (OVTI) This Earnings? - Analyst Blog Feb 24 2015
    Amarin to Report Fourth Quarter and Year-End 2014 Results and Host Conference Call on March 3, 2015 Feb 23 2015
    Can The Uptrend Continue for Amarin (AMRN)? - Tale of the Tape Feb 23 2015
    BUZZ-Amarin Corp Plc: Up after reported SunTrust action Feb 18 2015
    Amarin to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK